Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.990
+0.020 (1.02%)
At close: Jan 17, 2025, 4:00 PM
1.980
-0.010 (-0.50%)
After-hours: Jan 17, 2025, 4:41 PM EST
Cronos Group Revenue
Cronos Group had revenue of $34.26M in the quarter ending September 30, 2024, with 38.11% growth. This brings the company's revenue in the last twelve months to $111.23M, up 30.31% year-over-year. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.
Revenue (ttm)
$111.23M
Revenue Growth
+30.31%
P/S Ratio
n/a
Revenue / Employee
$312,441
Employees
356
Market Cap
763.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
CRON News
- 4 days ago - Top Canadian Cannabis Companies Poised for Market Growth in 2025 - MarijuanaStocks
- 22 days ago - Top Canadian Marijuana Stocks For Your 2025 Watchlist - MarijuanaStocks
- 24 days ago - Cannabis sector limps into 2025 because ‘the gold rush is over' - Market Watch
- 25 days ago - 2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now - MarijuanaStocks
- 7 weeks ago - 3 Marijuana Stocks For Your Holiday Trading - MarijuanaStocks
- 2 months ago - Marijuana Industry Could Stay in Limbo Under Trump - WSJ
- 2 months ago - Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely - Market Watch
- 2 months ago - Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say - Market Watch